Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigms Two Arthritis Phase 2 Clinical Trials on Schedule

Nov 23, 2017 at 2:48 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment